In partnership with

Anna's Daybreak News

_{Just facts, you think for yourself}

Monday, 5:04 AM

March 23, 2026

Good morning news friend! Discover today’s defining stories and the future they set in motion. 📰🌟

Notice: If you’re reading this email in the Gmail app, you will not be able to see both of our health articles at the bottom. 👉 Click here to view the full newsletter online — it’s free and easy to read.

Trump’s Ultimatum

President Trump gave Iran 48 hours to reopen the Strait of Hormuz, threatening to destroy Iranian power plants if it remained closed.

Iran fired missiles on Israeli towns near the Negev nuclear center, injuring over 150.

The conflict, now in its fourth week, has caused over 4,000 deaths regionwide and displaced millions. Iran also targeted the Diego Garcia military base without damage.

The near closure of the Strait disrupted 20% of global oil supply, pushing Brent crude above $112 per barrel and raising gasoline, fertilizer, and metal prices worldwide. The U.A.E. and 21 countries pledged to secure safe passage.

Sources: AP News, Co, EuroNews, Bloomberg 

Airport ICE

President Trump warned he will deploy ICE agents to airports starting March 27 if Congress doesn’t fund the Department of Homeland Security.

The funding deadlock has halted TSA officer pay for over five weeks, leading to 375 resignations and up to 40% absenteeism at some airports, causing long security lines during spring break.

ICE agents would assist TSA with security tasks and immigration arrests, focusing on individuals from Somalia. Democrats pushed to fund TSA alone, but Republicans demand DHS-wide funding, including ICE.

Elon Musk offered to pay TSA salaries, though details are unclear. If no deal is reached by March 27, TSA pay stoppages and airport disruptions risk worsening during a busy travel period.

Sources: WallStreetJournal, AP News, Bloomberg

AI Career Shift

A Harvard survey finds 59% of Americans aged 18-29 fear AI threatens jobs, with 41% saying AI reduces work meaning.

Stanford data shows a 16% drop in AI-exposed jobs (software developers, customer service) among 22-25-year-olds from late 2022 to 2025. Twenty percent rise in vocational college enrollment reflects shifts toward AI-resistant trades like electricians and firefighters.

Forty-four percent of 16-34-year-olds considered career changes due to AI, versus 4% of those 55+. Some young adults start AI ventures; one raised $4 million for an AI tutor.

Despite fears, young workers respond variably: pivoting careers, innovating with AI, or building independent businesses less vulnerable to automation.

Sources: WallStreetJournal

Peptide Market Surge

Injectable peptides, mainly from China, are used for weight loss, muscle recovery, and skin health, often sold online without FDA approval.

In 2023, the FDA banned 14 peptides due to safety concerns like immune reactions. Health Secretary Robert F. Kennedy Jr. plans to ease restrictions, allowing licensed U.S. compounding pharmacies to prepare them legally, aiming to reduce gray market risks.

The global peptide therapeutics market is projected to grow from $84.2 billion in 2023 to $162.4 billion by 2035. Critics warn of safety risks; two women fell ill in 2025 after peptide injections.

The FDA’s upcoming decision will impact market access and regulation.

Sources: WallStreetJournal, Bitget

DNA Bots

Scientists have developed DNA-based molecular robots capable of navigating bloodstreams and delivering drugs to target cells, such as cancer.

These robots use DNA strand displacement and external triggers (electric, magnetic, light) to change shape and function. Early devices include DNA machines that capture SARS-CoV-2, combining detection and therapy.

Beyond medicine, DNA robots can position nanoparticles with sub-nanometer precision, enabling atomic manufacturing and molecular computers. Challenges include controlling movements amid Brownian motion, limited robot function, and lack of comprehensive mechanical data and simulation tools.

Experts call for standardized DNA part libraries, AI design tools, and improved bio-manufacturing. The research aims to create programmable, intelligent molecular machines.

Sources: SciTechDaily

Reprogramming Cancer

Researchers developed a new cancer treatment that reprograms T cells inside the body, bypassing the need to remove and engineer cells externally as in traditional CAR-T therapy.

The approach uses two particles to deliver CRISPR-Cas9: one targets T cells via CD3 protein, the other inserts cancer-fighting receptors into the T cell genome.

In mouse models, this method eradicated aggressive leukemia, multiple myeloma, and solid tumors within two weeks, with engineered T cells comprising up to 40% of immune cells in some organs.

The in vivo technique outperformed lab-made CAR-T cells, preserving T cell stemness and proliferative capacity, potentially cutting costs and wait times. Azalea Therapeutics was formed to pursue clinical trials.

Sources: SciTechDaily

“Every man riding this river has got a lucky star somewhere up in the sky, even if he's the sorriest looking tramp on the deck. If a fellow thinks he is entirely cursed and hasn't got one, it is generally just because he’s been staring at the wrong patch of the heavens.”

Baked with love,

Anna Eisenberg ❤️

*Terms & Conditions apply. Not available if with Metro in the last 180 days. If using >35GB/mo. May notice reduced speeds.